TANG CAPITAL PARTNERS LP 13D and 13G filings for Bolt Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:00 pm Purchase |
2023-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT |
TANG CAPITAL PARTNERS LP | 3,652,244 9.600% |
919,994 (+33.67%) |
Filing |
| 2023-04-20 4:13 pm Purchase |
2023-04-10 | 13G | Bolt Biotherapeutics, Inc. BOLT |
TANG CAPITAL PARTNERS LP | 2,732,250 7.200% |
2,732,250 (New Position) |
Filing |